Fjarde Ap Fonden Viatris Inc Transaction History

Fjarde Ap Fonden

$9.04 Billion
Q1 2024

A detailed history of Fjarde Ap Fonden transactions in Viatris Inc stock. As of the latest transaction made, Fjarde Ap Fonden holds 206,290 shares of VTRS stock, worth $2.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

206,290

Previous 192,490 7.17%

Holding current value

$2.4 Million

Previous $2.09 Million 18.13%

% of portfolio

0.03%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$11.27 - $13.53 $155,526 - $186,714	13,800 Added 7.17%	206,290 $2.46 Million
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $322,736 - $399,280	-36,800 Reduced 16.05%	192,490 $2.09 Million
Q3 2023 Oct 23, 2023	SELL	$9.59 - $11.35 $15,344 - $18,160	-1,600 Reduced 0.69%	229,290 $2.26 Million
Q2 2023 Aug 02, 2023	SELL	$9.02 - $10.29 $459,118 - $523,760	-50,900 Reduced 18.06%	230,890 $2.3 Million
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $79,120 - $105,436	8,600 Added 3.15%	281,790 $2.71 Million
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $349,672 - $463,556	40,100 Added 17.2%	273,190 $3.04 Million
Q2 2022 Aug 11, 2022	SELL	$9.95 - $12.27 $1.75 Million - $2.16 Million	-176,100 Reduced 43.04%	233,090 $2.44 Million
Q1 2022 May 13, 2022	BUY	$9.81 - $15.4 $115,758 - $181,720	11,800 Added 2.97%	409,190 $4.45 Million
Q4 2021 Feb 15, 2022	SELL	$12.09 - $14.68 $70,122 - $85,144	-5,800 Reduced 1.44%	397,390 $5.38 Million
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $270,300 - $308,652	20,400 Added 5.33%	403,190 $5.46 Million
Q1 2021 May 17, 2021	BUY	$13.59 - $18.54 $462,060 - $630,360	34,000 Added 9.75%	382,790 $5.35 Million
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $4.99 Million - $6.54 Million	348,790 New	348,790 $6.54 Million

Others Institutions Holding VTRS

# of Institutions

1,085

Shares Held

970M

Call Options Held

2.63M

Put Options Held

2.15M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14.1B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account